A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
Merus B.V.
Merus B.V.
Boehringer Ingelheim
Ensem Therapeutics
AstraZeneca
Johnson & Johnson Enterprise Innovation Inc.
Varian, a Siemens Healthineers Company
Johnson & Johnson Enterprise Innovation Inc.
PMV Pharmaceuticals, Inc
Exelixis
VSPharmTech Co.,Ltd.
Kivu Bioscience Inc.
AstraZeneca
Bicara Therapeutics
STORM Therapeutics LTD
Pfizer
Boehringer Ingelheim
Tempus AI
Aktis Oncology, Inc.
Tubulis GmbH
Eli Lilly and Company
Neonc Technologies, Inc.
Coherus Oncology, Inc.
ViroMissile, Inc.
Ipsen
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Jazz Pharmaceuticals
AstraZeneca
Seagen Inc.
Merus B.V.
AstraZeneca
Radiopharm Theranostics, Ltd
Arvinas Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Genentech, Inc.
ALX Oncology Inc.
AbbVie
Clasp Therapeutics, Inc.
BioNTech SE
Exscientia AI Limited
Normunity AccelCo, Inc.
Eli Lilly and Company
Betta Pharmaceuticals Co., Ltd.
IDEAYA Biosciences
DualityBio Inc.
MacroGenics
Avacta Life Sciences Ltd
Pfizer